Skip to content

MICROBOT MEDICAL INC.: 10-Q filed 2014-11-13

What MICROBOT MEDICAL INC. reported in its quarterly report filed 2014-11-13 (fiscal Q3 2014): 35 published measures, 91 facts as tagged in accession 0001193125-14-411251.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-13
Fiscal period
fiscal Q3 2014
Accession
0001193125-14-411251 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MICROBOT MEDICAL INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-3042,770,112USD
At 2013-12-3141,557,174USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-3027,024,630USD
At 2013-12-3126,603,462USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-3015,745,482USD
At 2013-12-3114,953,712USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-3032,212,589USD
At 2013-12-3130,585,424USD
At 2013-09-3020,955,293USD
At 2012-12-318,471,275USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-2,757,186USD92
2014-01-01 to 2014-09-30-22,492,666USD273
2013-07-01 to 2013-09-30-7,191,653USD92
2013-01-01 to 2013-09-30-19,476,782USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-20,960,576USD273
2013-01-01 to 2013-09-30-16,432,180USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-09-30598,432USD273
2013-01-01 to 2013-09-304,556,406USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-07-01 to 2014-09-30269,664USD92
2014-01-01 to 2014-09-30851,348USD273
2013-07-01 to 2013-09-30324,792USD92
2013-01-01 to 2013-09-30890,689USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-09-3023,191,816USD273
2013-01-01 to 2013-09-3019,634,538USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-598,432USD273
2013-01-01 to 2013-09-309,284,127USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-30-410,023,000USD
At 2013-12-31-387,530,334USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-305,126,112USD
At 2013-12-315,304,684USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-09-301,543,577USD273
2013-01-01 to 2013-09-302,033,228USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-6,517,176USD92
2014-01-01 to 2014-09-30-21,520,840USD273
2013-07-01 to 2013-09-30-6,656,065USD92
2013-01-01 to 2013-09-30-19,134,477USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-3033,562,518USD
At 2013-12-3131,840,455USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-07-01 to 2014-09-30311,349USD92
2014-01-01 to 2014-09-301,035,061USD273
2013-07-01 to 2013-09-30382,119USD92
2013-01-01 to 2013-09-30785,122USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-307,869,336USD
At 2013-12-319,132,116USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-301,216,980USD
At 2013-12-311,151,903USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-09-302,093,602USD
At 2013-12-312,139,294USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-09-3070,495USD
At 2013-12-31108,815USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-306,728,677USD92
2014-01-01 to 2014-09-3022,148,652USD273
2013-07-01 to 2013-09-306,895,114USD92
2013-01-01 to 2013-09-3019,795,009USD273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-30211,501USD92
2014-01-01 to 2014-09-30627,812USD273
2013-07-01 to 2013-09-30239,049USD92
2013-01-01 to 2013-09-30660,532USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-07-01 to 2014-09-302,071,198USD92
2014-01-01 to 2014-09-306,494,595USD273
2013-07-01 to 2013-09-301,710,749USD92
2013-01-01 to 2013-09-305,180,027USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-07-01 to 2014-09-304,657,479USD92
2014-01-01 to 2014-09-3015,654,057USD273
2013-07-01 to 2013-09-305,184,365USD92
2013-01-01 to 2013-09-3014,553,145USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-3068,660,276shares
At 2013-12-3155,138,311shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-09-30179,737USD
At 2013-12-31252,101USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-09-301,584,046USD
At 2013-12-311,835,717USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-30399,672USD
At 2013-12-31413,717USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-09-302,610,659USD
At 2013-12-314,067,916USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-09-30992,612USD273
2013-01-01 to 2013-09-30730,504USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-07-01 to 2014-09-3075,000USD92

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-7,244USD92
2014-01-01 to 2014-09-30-38,128USD273
2013-07-01 to 2013-09-30-10,094USD92
2013-01-01 to 2013-09-308,475USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-01 to 2014-09-303,759,990USD92
2014-01-01 to 2014-09-30-971,826USD273
2013-07-01 to 2013-09-30-535,588USD92
2013-01-01 to 2013-09-30-342,305USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-09-3018,952,721USD273
2013-01-01 to 2013-09-306,115,442USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-37,121USD273
2013-01-01 to 2013-09-30-57,569USD273

Inspect the source

Entity
MICROBOT MEDICAL INC. / CIK 0000883975
Captured
2026-09-20T05:02:19.185Z
SEC response SHA-256
5fc792c757c83821aa0cd636b3655419924829213ef914d8be1d9f56dce19054

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000883975.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))